| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.646 | 0.013 | 0.646 | Aldehyde oxidase inhibitor | 0.386 0.049 CID_4342 | ||
| 0.596 | 0.004 | 0.596 | Sigma receptor agonist | 0.512 0.009 CID_4342 | ||
| 0.572 | 0.011 | 0.572 | GABA C receptor rho-3 antagonist | 0.384 0.069 CID_4342 | ||
| 0.55 | 0.009 | 0.55 | Superoxide dismutase inhibitor | 0.401 0.027 CID_4342 | ||
| 0.54 | 0.022 | 0.591 | 5 Hydroxytryptamine release inhibitor | 0.591 0.012 CID_4342 | CID_4342 | |
| 0.513 | 0.004 | 0.513 | Tyrosine 3 hydroxylase inhibitor | 0.423 0.006 CID_4342 | ||
| 0.494 | 0.016 | 0.494 | Cardiotonic | 0.441 0.022 CID_4342 | ||
| 0.46 | 0.005 | 0.46 | Anesthetic local | 0.324 0.01 CID_4342 | ||
| 0.457 | 0.006 | 0.457 | MAP kinase kinase 2 inhibitor | 0.359 0.019 CID_4342 | ||
| 0.447 | 0.015 | 0.447 | Peroxidase inhibitor | 0.271 0.043 CID_4342 | ||
| 0.434 | 0.073 | 0.459 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.459 0.056 CID_4342 | CID_4342 | |
| 0.379 | 0.026 | 0.379 | Psychostimulant | 0.202 0.079 CID_4342 | ||
| 0.356 | 0.013 | 0.356 | Lipocortins synthesis antagonist | 0.17 0.08 CID_4342 | ||
| 0.35 | 0.01 | 0.35 | Nav1.2 sodium channel blocker | 0.301 0.015 CID_4342 | ||
| 0.336 | 0.012 | 0.336 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.258 0.029 CID_4342 | ||
| 0.318 | 0.009 | 0.318 | Chelator | 0.3 0.011 CID_4342 | ||
| 0.358 | 0.05 | 0.358 | Spasmolytic | 0.274 0.081 CID_4342 | ||
| 0.314 | 0.011 | 0.314 | DNA intercalator | 0.254 0.016 CID_4342 | ||
| 0.335 | 0.034 | 0.35 | Interleukin agonist | 0.35 0.029 CID_4342 | CID_4342 | |
| 0.332 | 0.034 | 0.332 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.201 0.074 CID_4342 | ||
| 0.305 | 0.017 | 0.329 | Neuropeptide Y2 antagonist | 0.329 0.011 CID_4342 | CID_4342 | |
| 0.32 | 0.033 | 0.32 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.224 0.075 CID_4342 | ||
| 0.33 | 0.045 | 0.33 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.285 0.076 CID_4342 | ||
| 0.295 | 0.013 | 0.295 | Nitric-oxide synthase stimulant | 0.247 0.035 CID_4342 | ||
| 0.296 | 0.026 | 0.328 | Peptidyltransferase inhibitor | 0.328 0.016 CID_4342 | CID_4342 | |
| 0.318 | 0.048 | 0.344 | Insulysin inhibitor | 0.344 0.036 CID_4342 | CID_4342 | |
| 0.282 | 0.012 | 0.282 | MAP kinase kinase 3 inhibitor | 0.212 0.09 CID_4342 | ||
| 0.28 | 0.023 | 0.28 | I kappa B kinase epsilon inhibitor | 0.205 0.067 CID_4342 | ||
| 0.309 | 0.054 | 0.309 | DNA damaging | 0.239 0.087 CID_4342 | ||
| 0.289 | 0.036 | 0.289 | Anesthetic general | 0.179 0.087 CID_4342 | ||
| 0.35 | 0.1 | 0.419 | Histamine release inhibitor | 0.419 0.066 CID_4342 | CID_4342 | |
| 0.288 | 0.038 | 0.321 | 5 Hydroxytryptamine 1E antagonist | 0.321 0.019 CID_4342 | CID_4342 | |
| 0.269 | 0.028 | 0.269 | Focal adhesion kinase 2 inhibitor | 0.235 0.046 CID_4342 | ||
| 0.248 | 0.012 | 0.248 | GABA C receptor rho-2 antagonist | 0.154 0.068 CID_4342 | ||
| 0.247 | 0.014 | 0.289 | Nav1.3 sodium channel blocker | 0.289 0.01 CID_4342 | CID_4342 | |
| 0.235 | 0.003 | 0.235 | Topoisomerase II beta inhibitor | 0.211 0.004 CID_4342 | ||
| 0.265 | 0.036 | 0.265 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 CID_4342 | ||
| 0.272 | 0.056 | 0.302 | Gastrin inhibitor | 0.302 0.032 CID_4342 | CID_4342 | |
| 0.233 | 0.021 | 0.233 | Adenylate cyclase inhibitor | 0.15 0.045 CID_4342 | ||
| 0.297 | 0.09 | 0.297 | Vasodilator, coronary | 0.237 0.148 CID_4342 | ||
| 0.225 | 0.02 | 0.312 | Death-associated protein kinase 2 inhibitor | 0.312 0.006 CID_4342 | CID_4342 | |
| 0.285 | 0.085 | 0.313 | Interleukin 2 agonist | 0.313 0.065 CID_4342 | CID_4342 | |
| 0.25 | 0.052 | 0.25 | ErbB-1 antagonist | 0.17 0.133 CID_4342 | ||
| 0.265 | 0.067 | 0.265 | 5 Hydroxytryptamine uptake stimulant | 0.208 0.137 CID_4342 | ||
| 0.227 | 0.031 | 0.227 | Phospholipase C inhibitor | 0.161 0.087 CID_4342 | ||
| 0.238 | 0.044 | 0.238 | LIM domain kinase 1 inhibitor | 0.189 0.068 CID_4342 | ||
| 0.251 | 0.059 | 0.251 | MAP-kinase-activated kinase 5 inhibitor | 0.172 0.145 CID_4342 | ||
| 0.205 | 0.013 | 0.213 | Telomerase inhibitor | 0.213 0.013 CID_4342 | CID_4342 | |
| 0.271 | 0.088 | 0.28 | Immunostimulant | 0.28 0.085 CID_4342 | CID_4342 | |
| 0.193 | 0.009 | 0.193 | GABA C receptor rho-1 antagonist | 0.096 0.068 CID_4342 | ||
| 0.207 | 0.024 | 0.207 | Alkylator | 0.173 0.036 CID_4342 | ||
| 0.225 | 0.053 | 0.225 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.125 0.11 CID_4342 | ||
| 0.226 | 0.057 | 0.233 | DNA methyltransferase I inhibitor | 0.233 0.054 CID_4342 | CID_4342 | |
| 0.229 | 0.061 | 0.229 | DNA methylase inhibitor | 0.224 0.064 CID_4342 | ||
| 0.199 | 0.033 | 0.199 | Catenin beta inhibitor | 0.175 0.058 CID_4342 | ||
| 0.182 | 0.017 | 0.182 | GABA C receptor antagonist | |||
| 0.179 | 0.015 | 0.179 | Porphobilinogen synthase inhibitor | 0.123 0.027 CID_4342 | ||
| 0.195 | 0.035 | 0.195 | Acetylcholinesterase inhibitor | 0.107 0.094 CID_4342 | ||
| 0.174 | 0.016 | 0.174 | Sphingomyelinase inhibitor | 0.161 0.02 CID_4342 | ||
| 0.172 | 0.014 | 0.172 | NADH dehydrogenase inhibitor | 0.108 0.036 CID_4342 | ||
| 0.167 | 0.009 | 0.167 | Acetylcholine release stimulant | 0.129 0.035 CID_4342 | ||
| 0.157 | 0.003 | 0.157 | Epithelial sodium channel blocker | 0.089 0.009 CID_4342 | ||
| 0.17 | 0.016 | 0.17 | Folate antagonist | 0.121 0.038 CID_4342 | ||
| 0.193 | 0.041 | 0.193 | Heat shock protein 90 antagonist | 0.144 0.081 CID_4342 | ||
| 0.164 | 0.015 | 0.164 | Electrolyte absorption antagonist | 0.149 0.02 CID_4342 | ||
| 0.265 | 0.117 | 0.265 | Transcription factor NF kappa B inhibitor | 0.198 0.17 CID_4342 | ||
| 0.151 | 0.005 | 0.151 | Heat shock protein 90 beta antagonist | 0.095 0.013 CID_4342 | ||
| 0.194 | 0.049 | 0.194 | Cholinergic | |||
| 0.174 | 0.031 | 0.221 | Cyclooxygenase 3 inhibitor | 0.221 0.013 CID_4342 | CID_4342 | |
| 0.177 | 0.035 | 0.177 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 CID_4342 | ||
| 0.227 | 0.088 | 0.269 | Calpain inhibitor | 0.269 0.049 CID_4342 | CID_4342 | |
| 0.172 | 0.033 | 0.172 | Adenylate cyclase stimulant | |||
| 0.211 | 0.072 | 0.211 | Amyloid beta aggregation inhibitor | 0.174 0.092 CID_4342 | ||
| 0.142 | 0.004 | 0.142 | Phospholipase D inhibitor | 0.12 0.006 CID_4342 | ||
| 0.169 | 0.032 | 0.169 | Alpha 2b adrenoreceptor antagonist | 0.105 0.071 CID_4342 | ||
| 0.163 | 0.026 | 0.163 | Carbonic anhydrase XV inhibitor | 0.111 0.054 CID_4342 | ||
| 0.297 | 0.16 | 0.297 | Calcium channel L-type activator | |||
| 0.181 | 0.045 | 0.181 | Toll-Like receptor 9 antagonist | |||
| 0.225 | 0.088 | 0.225 | DNA synthesis inhibitor | |||
| 0.16 | 0.025 | 0.16 | Potassium channel (Ca-activated) activator | |||
| 0.144 | 0.011 | 0.144 | Histamine H2 receptor antagonist | 0.108 0.028 CID_4342 | ||
| 0.264 | 0.131 | 0.264 | Calcium channel activator | |||
| 0.159 | 0.027 | 0.175 | Papain-like protease (SARS coronavirus) inhibitor | 0.175 0.018 CID_4342 | CID_4342 | |
| 0.268 | 0.137 | 0.406 | Calpain 2 inhibitor | 0.406 0.058 CID_4342 | CID_4342 | |
| 0.204 | 0.074 | 0.204 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.145 0.135 CID_4342 | ||
| 0.138 | 0.009 | 0.138 | Histone deacetylase inhibitor | 0.134 0.01 CID_4342 | ||
| 0.171 | 0.042 | 0.171 | Toll-Like receptor antagonist | |||
| 0.132 | 0.006 | 0.132 | Estrogen-related receptor beta agonist | 0.103 0.021 CID_4342 | ||
| 0.156 | 0.032 | 0.156 | Butyrylcholinesterase inhibitor | 0.102 0.06 CID_4342 | ||
| 0.175 | 0.055 | 0.175 | Acetylcholine M1 receptor antagonist | 0.128 0.097 CID_4342 | ||
| 0.138 | 0.019 | 0.138 | Toll-Like receptor 3 antagonist | |||
| 0.175 | 0.057 | 0.175 | Diuretic | 0.152 0.076 CID_4342 | ||
| 0.141 | 0.03 | 0.141 | Adenylate kinase inhibitor | 0.092 0.083 CID_4342 | ||
| 0.157 | 0.046 | 0.157 | Nav1.6 sodium channel blocker | |||
| 0.153 | 0.044 | 0.153 | Cathepsin H inhibitor | 0.107 0.095 CID_4342 | ||
| 0.3 | 0.194 | 0.399 | Caspase 9 stimulant | 0.399 0.112 CID_4342 | CID_4342 | |
| 0.161 | 0.056 | 0.161 | Hemostatic | 0.159 0.058 CID_4342 | ||
| 0.16 | 0.055 | 0.16 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.139 0.094 CID_4342 | ||
| 0.123 | 0.019 | 0.123 | Myeloperoxidase inhibitor | |||
| 0.108 | 0.004 | 0.108 | Dihydropteroate synthase inhibitor | 0.071 0.008 CID_4342 | ||
| 0.184 | 0.081 | 0.223 | Growth factor agonist | 0.223 0.045 CID_4342 | CID_4342 | |
| 0.137 | 0.035 | 0.143 | Platelet activating factor alpha antagonist | 0.143 0.033 CID_4342 | CID_4342 | |
| 0.129 | 0.027 | 0.129 | MAP kinase kinase 1 inhibitor | 0.086 0.076 CID_4342 | ||
| 0.105 | 0.004 | 0.105 | Ryanodine receptor antagonist | 0.063 0.029 CID_4342 | ||
| 0.16 | 0.06 | 0.16 | CF transmembrane conductance regulator agonist | 0.139 0.098 CID_4342 | ||
| 0.149 | 0.05 | 0.149 | Topoisomerase II inhibitor | 0.118 0.068 CID_4342 | ||
| 0.152 | 0.054 | 0.284 | Alpha-N-acetylglucosaminidase inhibitor | 0.284 0.018 CID_4342 | CID_4342 | |
| 0.166 | 0.069 | 0.166 | Interleukin 6 antagonist | |||
| 0.139 | 0.042 | 0.177 | Falcipain 3 inhibitor | 0.177 0.025 CID_4342 | CID_4342 | |
| 0.163 | 0.067 | 0.163 | Cyclin-dependent kinase 8 inhibitor | 0.156 0.074 CID_4342 | ||
| 0.115 | 0.02 | 0.115 | Phenylalanine 4-hydroxylase inhibitor | 0.072 0.044 CID_4342 | ||
| 0.123 | 0.028 | 0.123 | Polo-like kinase-1 inhibitor | 0.112 0.035 CID_4342 | ||
| 0.17 | 0.077 | 0.17 | Tumour necrosis factor antagonist | |||
| 0.172 | 0.08 | 0.172 | MAP kinase kinase 5 inhibitor | |||
| 0.265 | 0.172 | 0.265 | MAP kinase kinase 6 inhibitor | |||
| 0.127 | 0.036 | 0.139 | Interleukin 2 antagonist | 0.139 0.025 CID_4342 | CID_4342 | |
| 0.185 | 0.093 | 0.214 | 5 Hydroxytryptamine 3E antagonist | 0.214 0.043 CID_4342 | CID_4342 | |
| 0.125 | 0.035 | 0.125 | Nitric-oxide synthase inhibitor | |||
| 0.094 | 0.006 | 0.094 | Sodium/calcium exchanger inhibitor | 0.054 0.027 CID_4342 | ||
| 0.151 | 0.064 | 0.151 | Ribosomal protein S6 kinase inhibitor | |||
| 0.118 | 0.031 | 0.118 | Histamine N-methyltransferase inhibitor | |||
| 0.161 | 0.076 | 0.161 | Heat shock protein 90 alpha antagonist | 0.137 0.101 CID_4342 | ||
| 0.137 | 0.053 | 0.137 | Acetylcholine muscarinic antagonist | 0.111 0.078 CID_4342 | ||
| 0.088 | 0.004 | 0.093 | Delayed rectifier potassium channel blocker | 0.093 0.004 CID_4342 | CID_4342 | |
| 0.19 | 0.106 | 0.19 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.184 0.11 CID_4342 | ||
| 0.091 | 0.009 | 0.091 | Histone deacetylase class I inhibitor | 0.082 0.01 CID_4342 | ||
| 0.189 | 0.107 | 0.189 | Antiamyloidogenic | |||
| 0.111 | 0.031 | 0.111 | I kappa B kinase inhibitor | 0.08 0.06 CID_4342 | ||
| 0.087 | 0.009 | 0.099 | Carbonic anhydrase IV inhibitor | 0.099 0.007 CID_4342 | CID_4342 | |
| 0.092 | 0.015 | 0.092 | CC chemokine 2 receptor antagonist | 0.075 0.021 CID_4342 | ||
| 0.082 | 0.007 | 0.082 | Adenylate cyclase 1 inhibitor | |||
| 0.123 | 0.048 | 0.123 | GABA C receptor agonist | |||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.08 | 0.008 | 0.08 | Thymidylate synthase inhibitor | 0.042 0.039 CID_4342 | ||
| 0.163 | 0.091 | 0.163 | TRKC antagonist | |||
| 0.145 | 0.073 | 0.145 | Neuropeptide Y1 antagonist | 0.14 0.082 CID_4342 | ||
| 0.099 | 0.03 | 0.099 | Interferon agonist | |||
| 0.098 | 0.029 | 0.098 | Aminopeptidase I inhibitor | 0.08 0.042 CID_4342 | ||
| 0.128 | 0.059 | 0.149 | Proteasome inhibitor | 0.149 0.047 CID_4342 | CID_4342 | |
| 0.081 | 0.013 | 0.081 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.121 | 0.053 | 0.13 | Ferrochelatase inhibitor | 0.13 0.048 CID_4342 | CID_4342 | |
| 0.083 | 0.02 | 0.083 | I kappa B kinase 2 inhibitor | 0.063 0.043 CID_4342 | ||
| 0.08 | 0.018 | 0.08 | Gonadotropin-releasing hormone receptor agonist | 0.066 0.03 CID_4342 | ||
| 0.107 | 0.045 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.08 | 0.018 | 0.113 | Histone deacetylase SIRT3 inhibitor | 0.113 0.008 CID_4342 | CID_4342 | |
| 0.066 | 0.005 | 0.066 | Dopamine autoreceptor agonist | |||
| 0.117 | 0.057 | 0.134 | Mucolytic | 0.134 0.043 CID_4342 | CID_4342 | |
| 0.069 | 0.008 | 0.069 | Plasmepsin II inhibitor | 0.047 0.02 CID_4342 | ||
| 0.19 | 0.13 | 0.19 | 5 Hydroxytryptamine release stimulant | |||
| 0.115 | 0.055 | 0.115 | Aminopeptidase B inhibitor | 0.083 0.079 CID_4342 | ||
| 0.1 | 0.041 | 0.113 | Bcr-Abl kinase inhibitor | 0.113 0.03 CID_4342 | CID_4342 | |
| 0.097 | 0.039 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.083 | 0.027 | 0.083 | Potassium channel (Tandem pore domain) blocker | 0.082 0.029 CID_4342 | ||
| 0.104 | 0.048 | 0.104 | Potassium channel (Voltage-sensitive) activator | 0.103 0.049 CID_4342 | ||
| 0.093 | 0.038 | 0.093 | D-Ala-D-Ala ligase inhibitor | |||
| 0.074 | 0.019 | 0.074 | Glycine transporter 2 inhibitor | 0.072 0.02 CID_4342 | ||
| 0.126 | 0.071 | 0.168 | Toll-Like receptor 2 antagonist | 0.168 0.041 CID_4342 | CID_4342 | |
| 0.086 | 0.032 | 0.086 | MAP kinase kinase 7 inhibitor | 0.076 0.059 CID_4342 | ||
| 0.132 | 0.078 | 0.168 | Histone deacetylase SIRT1 inhibitor | 0.168 0.048 CID_4342 | CID_4342 | |
| 0.081 | 0.028 | 0.081 | Adenosine A1 receptor antagonist | |||
| 0.071 | 0.018 | 0.071 | Beta 2 adrenoreceptor agonist | 0.07 0.02 CID_4342 | ||
| 0.089 | 0.037 | 0.089 | Glutamate dehydrogenase inhibitor | 0.068 0.06 CID_4342 | ||
| 0.104 | 0.053 | 0.135 | Glutamate (mGluR7) agonist | 0.135 0.019 CID_4342 | CID_4342 | |
| 0.053 | 0.002 | 0.053 | Estrogen-related receptor gamma agonist | 0.037 0.003 CID_4342 | ||
| 0.108 | 0.058 | 0.118 | Urease inhibitor | 0.118 0.046 CID_4342 | CID_4342 | |
| 0.076 | 0.027 | 0.089 | Carbonic anhydrase I inhibitor | 0.089 0.022 CID_4342 | CID_4342 | |
| 0.108 | 0.059 | 0.108 | Alpha 2c adrenoreceptor antagonist | |||
| 0.135 | 0.087 | 0.205 | Cytidine deaminase inhibitor | 0.205 0.045 CID_4342 | CID_4342 | |
| 0.158 | 0.11 | 0.158 | Death-associated protein kinase 3 inhibitor | 0.144 0.133 CID_4342 | ||
| 0.073 | 0.025 | 0.073 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.068 | 0.021 | 0.068 | Phosphorylase inhibitor | 0.053 0.028 CID_4342 | ||
| 0.165 | 0.119 | 0.165 | Histone acetyltransferase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Growth hormone secretagogue receptor antagonist | 0.06 0.014 CID_4342 | ||
| 0.06 | 0.014 | 0.06 | AICAR transformylase inhibitor | 0.051 0.021 CID_4342 | ||
| 0.095 | 0.05 | 0.095 | Glutamate release inhibitor | |||
| 0.079 | 0.036 | 0.088 | Carbonic anhydrase inhibitor | 0.088 0.031 CID_4342 | CID_4342 | |
| 0.118 | 0.075 | 0.118 | Cholinergic antagonist | |||
| 0.089 | 0.047 | 0.097 | Topoisomerase II alpha inhibitor | 0.097 0.042 CID_4342 | CID_4342 | |
| 0.049 | 0.008 | 0.049 | Lysine carboxypeptidase inhibitor | 0.024 0.022 CID_4342 | ||
| 0.048 | 0.007 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 CID_4342 | ||
| 0.075 | 0.034 | 0.075 | Potassium channel (ATP-sensitive) blocker | 0.067 0.047 CID_4342 | ||
| 0.059 | 0.019 | 0.059 | Factor III inhibitor | 0.052 0.029 CID_4342 | ||
| 0.053 | 0.014 | 0.078 | Histone deacetylase 9 inhibitor | 0.078 0.008 CID_4342 | CID_4342 | |
| 0.096 | 0.057 | 0.096 | Alcohol dehydrogenase inhibitor | |||
| 0.114 | 0.076 | 0.114 | Acetylcholine antagonist | |||
| 0.082 | 0.044 | 0.082 | GABA aminotransferase inhibitor | |||
| 0.067 | 0.029 | 0.067 | Acetylcholine muscarinic agonist | |||
| 0.07 | 0.031 | 0.07 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.062 | 0.024 | 0.062 | Alpha-mannosidase inhibitor | 0.057 0.031 CID_4342 | ||
| 0.092 | 0.055 | 0.092 | Pim-3 kinase inhibitor | |||
| 0.067 | 0.031 | 0.078 | Carbonic anhydrase II inhibitor | 0.078 0.026 CID_4342 | CID_4342 | |
| 0.103 | 0.067 | 0.103 | Topoisomerase I inhibitor | |||
| 0.13 | 0.095 | 0.13 | Thiol protease inhibitor | 0.128 0.101 CID_4342 | ||
| 0.082 | 0.048 | 0.082 | Fibroblast growth factor 3 antagonist | |||
| 0.085 | 0.05 | 0.097 | CC chemokine 5 receptor agonist | 0.097 0.025 CID_4342 | CID_4342 | |
| 0.066 | 0.031 | 0.066 | Prolactin release inhibitor | |||
| 0.054 | 0.019 | 0.054 | Geranyltranstransferase inhibitor | |||
| 0.07 | 0.035 | 0.07 | Interferon inducer | |||
| 0.126 | 0.092 | 0.149 | Aurora-C kinase inhibitor | 0.149 0.052 CID_4342 | CID_4342 | |
| 0.085 | 0.052 | 0.085 | Platelet growth factor antagonist | 0.076 0.061 CID_4342 | ||
| 0.084 | 0.052 | 0.084 | Adrenaline agonist | 0.079 0.059 CID_4342 | ||
| 0.066 | 0.034 | 0.066 | Carbonic anhydrase stimulant | 0.06 0.04 CID_4342 | ||
| 0.039 | 0.007 | 0.039 | Purinergic P2Y15 antagonist | 0.033 0.012 CID_4342 | ||
| 0.069 | 0.037 | 0.081 | NMDA receptor agonist | 0.081 0.028 CID_4342 | CID_4342 | |
| 0.115 | 0.084 | 0.115 | DNA repair enzyme inhibitor | |||
| 0.046 | 0.015 | 0.046 | Opioid delta receptor agonist | |||
| 0.088 | 0.057 | 0.088 | Acetylcholine agonist | |||
| 0.068 | 0.038 | 0.068 | Adenosine A2a receptor antagonist | |||
| 0.098 | 0.068 | 0.098 | Nav1.1 sodium channel blocker | |||
| 0.112 | 0.082 | 0.112 | MAP kinase kinase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Glucose-6-phosphate dehydrogenase inhibitor | 0.042 0.019 CID_4342 | ||
| 0.07 | 0.04 | 0.07 | Adenosine A2 receptor antagonist | |||
| 0.119 | 0.089 | 0.119 | Calcium channel blocker | |||
| 0.097 | 0.068 | 0.097 | Check point kinase 2 inhibitor | |||
| 0.122 | 0.094 | 0.122 | Activin receptor-like kinase 2 inhibitor | |||
| 0.046 | 0.018 | 0.055 | Factor XIIIa inhibitor | 0.055 0.014 CID_4342 | CID_4342 | |
| 0.067 | 0.039 | 0.08 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 CID_4342 | CID_4342 | |
| 0.092 | 0.065 | 0.092 | Prolactin inhibitor | |||
| 0.142 | 0.116 | 0.184 | ATPase inhibitor | 0.184 0.053 CID_4342 | CID_4342 | |
| 0.122 | 0.096 | 0.122 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.155 | 0.13 | 0.155 | Neurotrophic factor enhancer | |||
| 0.061 | 0.036 | 0.061 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.107 | 0.082 | 0.107 | Calcium channel N-type blocker | |||
| 0.045 | 0.021 | 0.045 | Membrane dipeptidase inhibitor | |||
| 0.113 | 0.09 | 0.113 | Cyclin-dependent kinase 7 inhibitor | 0.101 0.099 CID_4342 | ||
| 0.074 | 0.052 | 0.074 | Rho-associated kinase I inhibitor | 0.068 0.059 CID_4342 | ||
| 0.037 | 0.015 | 0.038 | GHS receptor antagonist | 0.038 0.014 CID_4342 | CID_4342 | |
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.046 | 0.025 | 0.046 | Histamine H1 receptor agonist | |||
| 0.046 | 0.026 | 0.046 | Histamine H2 receptor agonist | |||
| 0.057 | 0.037 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.023 | 0.004 | 0.023 | CDK2/cyclin A3 inhibitor | 0.016 0.013 CID_4342 | ||
| 0.062 | 0.042 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CID_4342 | ||
| 0.158 | 0.139 | 0.158 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.032 | 0.013 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.149 | 0.13 | 0.149 | Anticonvulsant | |||
| 0.047 | 0.029 | 0.047 | Mannosidase inhibitor | 0.041 0.039 CID_4342 | ||
| 0.044 | 0.026 | 0.044 | Glutamate (mGluR1a) antagonist | |||
| 0.114 | 0.096 | 0.119 | Cytokine production inhibitor | 0.119 0.091 CID_4342 | CID_4342 | |
| 0.045 | 0.028 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.061 | 0.044 | 0.061 | Acetylcholine M2 receptor antagonist | |||
| 0.112 | 0.095 | 0.152 | Antibacterial (Helicobacter pylori) | 0.152 0.044 CID_4342 | CID_4342 | |
| 0.13 | 0.113 | 0.13 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.032 | 0.016 | 0.032 | CDK4/cyclin D3 inhibitor | |||
| 0.143 | 0.127 | 0.143 | Succinate dehydrogenase inhibitor | |||
| 0.027 | 0.011 | 0.027 | 5 Hydroxytryptamine 4 agonist | |||
| 0.03 | 0.015 | 0.03 | Histone deacetylase 1 inhibitor | |||
| 0.077 | 0.062 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.039 | 0.024 | 0.055 | Diamine oxidase inhibitor | 0.055 0.012 CID_4342 | CID_4342 | |
| 0.071 | 0.056 | 0.076 | Adenosine A3 receptor antagonist | 0.076 0.049 CID_4342 | CID_4342 | |
| 0.087 | 0.073 | 0.087 | Platelet activating factor beta antagonist | |||
| 0.041 | 0.028 | 0.041 | Thymidine kinase inhibitor | |||
| 0.065 | 0.051 | 0.065 | Potassium channel large-conductance Ca-activated activator | |||
| 0.021 | 0.008 | 0.021 | Adenosine A2a receptor agonist | 0.017 0.009 CID_4342 | ||
| 0.057 | 0.044 | 0.057 | Biliverdin reductase inhibitor | |||
| 0.038 | 0.025 | 0.069 | Histone deacetylase 7 inhibitor | 0.069 0.013 CID_4342 | CID_4342 | |
| 0.032 | 0.019 | 0.032 | AMPA 3 receptor antagonist | |||
| 0.099 | 0.086 | 0.099 | Calcium channel (voltage-sensitive) blocker | |||
| 0.035 | 0.023 | 0.035 | Adenosine uptake inhibitor | |||
| 0.127 | 0.114 | 0.127 | Polo-like kinase-3 inhibitor | |||
| 0.059 | 0.047 | 0.059 | NMDA 2C receptor antagonist | |||
| 0.088 | 0.076 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | 0.103 0.053 CID_4342 | CID_4342 | |
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.1 | 0.089 | 0.15 | CDK3/cyclin E inhibitor | 0.15 0.026 CID_4342 | CID_4342 | |
| 0.049 | 0.039 | 0.049 | NMDA 2A receptor antagonist | |||
| 0.019 | 0.009 | 0.019 | Adenosine A2 receptor agonist | 0.019 0.009 CID_4342 | ||
| 0.082 | 0.072 | 0.082 | Fibroblast growth factor 1 antagonist | |||
| 0.055 | 0.046 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.043 CID_4342 | CID_4342 | |
| 0.028 | 0.019 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.2 | 0.192 | 0.214 | Ca(v)3.3 blocker | 0.214 0.163 CID_4342 | CID_4342 | |
| 0.057 | 0.049 | 0.079 | NMDA receptor glycine site agonist | 0.079 0.029 CID_4342 | CID_4342 | |
| 0.021 | 0.013 | 0.023 | Factor XIII inhibitor | 0.023 0.01 CID_4342 | CID_4342 | |
| 0.138 | 0.13 | 0.191 | Cyclin-dependent kinase 3 inhibitor | 0.191 0.039 CID_4342 | CID_4342 | |
| 0.105 | 0.098 | 0.105 | Lck kinase inhibitor | |||
| 0.045 | 0.039 | 0.049 | Benzodiazepine antagonist | 0.049 0.028 CID_4342 | CID_4342 | |
| 0.044 | 0.038 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.034 CID_4342 | ||
| 0.075 | 0.07 | 0.102 | Glutathione S-transferase inhibitor | 0.102 0.035 CID_4342 | CID_4342 | |
| 0.053 | 0.047 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.092 | 0.086 | 0.092 | Platelet activating factor antagonist | |||
| 0.055 | 0.051 | 0.055 | Purinergic P2X1 antagonist | |||
| 0.02 | 0.016 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 CID_4342 | CID_4342 | |
| 0.006 | 0.002 | 0.006 | Reverse transcriptase (HBV) inhibitor | |||
| 0.08 | 0.076 | 0.1 | Potassium channel activator | 0.1 0.048 CID_4342 | CID_4342 | |
| 0.044 | 0.041 | 0.055 | Transforming growth factor beta 1 antagonist | 0.055 0.03 CID_4342 | CID_4342 | |
| 0.142 | 0.139 | 0.142 | Platelet aggregation inhibitor | |||
| 0.071 | 0.067 | 0.071 | Acetylcholine nicotinic antagonist | |||
| 0.078 | 0.075 | 0.091 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.091 0.062 CID_4342 | CID_4342 | |
| 0.036 | 0.034 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.037 | 0.036 | 0.037 | Acetylcholine M1 receptor agonist | |||
| 0.096 | 0.095 | 0.096 | MAO inhibitor | |||
| 0.047 | 0.046 | 0.047 | Toll-Like receptor 8 antagonist | |||
| 0.034 | 0.033 | 0.034 | ATM kinase inhibitor | |||
| 0.096 | 0.095 | 0.096 | TRKA antagonist | |||
| 0.064 | 0.065 | 0.072 | Rho-associated kinase II inhibitor | 0.072 0.054 CID_4342 | CID_4342 | |
| 0.085 | 0.089 | 0.087 | Expectorant | 0.087 0.085 CID_4342 | CID_4342 | |
| 0.056 | 0.062 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.053 CID_4342 | CID_4342 | |
| 0.187 | 0.194 | 0.206 | Antithrombotic | 0.206 0.169 CID_4342 | CID_4342 | |
| 0.053 | 0.062 | 0.06 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.044 CID_4342 | CID_4342 | |
| 0.076 | 0.085 | 0.081 | Hematopoietic | 0.081 0.071 CID_4342 | CID_4342 | |
| 0.055 | 0.065 | 0.063 | Beta adrenoreceptor antagonist | 0.063 0.05 CID_4342 | CID_4342 | |
| 0.238 | 0.249 | 0.243 | MAP kinase 1 inhibitor | 0.243 0.242 CID_4342 | CID_4342 | |
| 0.038 | 0.049 | 0.074 | Neuraminidase (Influenza A) inhibitor | 0.074 0.006 CID_4342 | CID_4342 | |
| 0.009 | 0.021 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CID_4342 | CID_4342 | |
| 0.059 | 0.072 | 0.093 | Epoxide hydrolase inhibitor | 0.093 0.03 CID_4342 | CID_4342 | |
| 0.029 | 0.042 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | 0.035 0.021 CID_4342 | CID_4342 | |
| 0.034 | 0.049 | 0.047 | Carbonic anhydrase VII inhibitor | 0.047 0.031 CID_4342 | CID_4342 | |
| 0.017 | 0.035 | 0.03 | Nicotinamide phosphoribosyltransferase inhibitor | 0.03 0.019 CID_4342 | CID_4342 | |
| 0.181 | 0.199 | 0.241 | Vasodilator, peripheral | 0.241 0.134 CID_4342 | CID_4342 | |
| 0.012 | 0.031 | 0.018 | Apolipoprotein B inhibitor | 0.018 0.015 CID_4342 | CID_4342 | |
| 0.097 | 0.116 | 0.106 | Transcription factor STAT6 inhibitor | 0.106 0.089 CID_4342 | CID_4342 | |
| 0.046 | 0.066 | 0.061 | DNA helicase inhibitor | 0.061 0.026 CID_4342 | CID_4342 | |
| 0.023 | 0.043 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.038 0.012 CID_4342 | CID_4342 | |
| 0.089 | 0.11 | 0.096 | TRPA1 agonist | 0.096 0.095 CID_4342 | CID_4342 | |
| 0.014 | 0.038 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 CID_4342 | CID_4342 | |
| 0.177 | 0.202 | 0.366 | Beta lactamase inhibitor | 0.366 0.11 CID_4342 | CID_4342 | |
| 0.049 | 0.082 | 0.094 | Catalase inhibitor | 0.094 0.041 CID_4342 | CID_4342 | |
| 0.024 | 0.058 | 0.035 | Histone deacetylase 8 inhibitor | 0.035 0.034 CID_4342 | CID_4342 | |
| 0.157 | 0.199 | 0.278 | Transcription factor STAT3 inhibitor | 0.278 0.064 CID_4342 | CID_4342 | |
| 0.191 | 0.235 | 0.289 | DNA directed DNA polymerase inhibitor | 0.289 0.168 CID_4342 | CID_4342 | |
| 0.167 | 0.213 | 0.231 | Angiogenesis inhibitor | 0.231 0.138 CID_4342 | CID_4342 | |
| 0.056 | 0.109 | 0.101 | Stem cell growth factor agonist | 0.101 0.044 CID_4342 | CID_4342 | |
| 0.027 | 0.082 | 0.092 | Melanin-concentrating hormone receptor 1 antagonist | 0.092 0.016 CID_4342 | CID_4342 | |
| 0.073 | 0.129 | 0.126 | Histone deacetylase class III inhibitor | 0.126 0.065 CID_4342 | CID_4342 | |
| 0.059 | 0.116 | 0.078 | Neuropeptide Y antagonist | 0.078 0.062 CID_4342 | CID_4342 | |
| 0.147 | 0.214 | 0.274 | Thyroid hormone antagonist | 0.274 0.108 CID_4342 | CID_4342 | |
| 0.052 | 0.122 | 0.077 | Glycine receptor antagonist | 0.077 0.061 CID_4342 | CID_4342 | |
| 0.179 | 0.249 | 0.275 | Transcription factor inhibitor | 0.275 0.17 CID_4342 | CID_4342 | |
| 0.031 | 0.104 | 0.056 | Myc inhibitor | 0.056 0.035 CID_4342 | CID_4342 | |
| 0.141 | 0.215 | 0.273 | Thyroid hormone beta antagonist | 0.273 0.103 CID_4342 | CID_4342 | |
| 0.171 | 0.248 | 0.303 | DNA polymerase beta inhibitor | 0.303 0.164 CID_4342 | CID_4342 | |
| 0.093 | 0.182 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | 0.126 0.083 CID_4342 | CID_4342 | |
| 0.036 | 0.131 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_4342 | CID_4342 | |
| 0.149 | 0.243 | 0.261 | Transcription factor STAT inhibitor | 0.261 0.079 CID_4342 | CID_4342 | |
| 0.026 | 0.122 | 0.119 | Neuraminidase inhibitor | 0.119 0.01 CID_4342 | CID_4342 | |
| 0.025 | 0.162 | 0.071 | Vanilloid antagonist | 0.071 0.055 CID_4342 | CID_4342 | |
| 0.096 | 0.236 | 0.145 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.11 CID_4342 | CID_4342 | |
| 0.007 | 0.178 | 0.026 | Melatonin antagonist | 0.026 0.022 CID_4342 | CID_4342 | |
| 0.05 | 0.228 | 0.099 | Caspase 3 inhibitor | 0.099 0.093 CID_4342 | CID_4342 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |